Kabi

Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's extensive portfolio includes I.V. generic drugs, infusion therapies, and medical devices used for the administration of these products. In recent years, Fresenius Kabi has aggressively expanded into the biosimilars market, developing a robust pipeline of monoclonal antibodies for oncology and autoimmune diseases. They are a leading provider of clinical nutrition products, offering both parenteral and enteral nutrition solutions for critically and chronically ill patients. Additionally, the company provides contract manufacturing services (CDMO) for complex formulations and biologics, leveraging its global manufacturing network. Headquartered in Germany, Fresenius Kabi operates as a key business segment of the Fresenius SE & Co. KGaA group.